Close

Drug Research

Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance

Samsung Biologics announced a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance. Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug...

As Lonza CEO departs, Catalent scoops up rival CDMO’s bioscience business head to lead biologics

Mere hours after it surfaced that Lonzaโ€™s CEO, Pierre-Alain Ruffieux, will step down, the Swiss CDMO has lost another major executive. And this time, the exec is jumping ship to U.S. contract manufacturing rival Catalent. Monday, Catalent named Lonzaโ€™s David...

Drug Diversion Detection Through AI Effective In Hospitals

Research conducted by Wolters Kluwer, an information and software company, suggests that artificial intelligence (AI) can potentially reduce drug diversion in hospitals. The study revealed that over half of managers who implemented AI-based diversion detection programs reported increased confidence...

Sygnature Discoveryโ€™s hit finding expertise in high demand as cardiac biotech, River BioMedics, receives an additional โ‚ฌ2M seed investment

Sygnature Discovery (Sygnature) is delighted to announce that its customer, River BioMedics, has raised an additional โ‚ฌ2M in seed funding to continue its life-saving cardiovascular drug research. Libertatis Ergo Holding, an independent subsidiary of Leiden University joins the investment syndicate...

CordenPharma Inaugurates Increased Peptide Production of the Largest Worldwide SPPS Manufacturing Plant to Meet Growing Market Demand

ย Following the signature of a multi-year large scaleย peptideย manufacturingย agreement earlier this year,ย CordenPharmaย is pleased to announce the inauguration ofย increasedย commercialย peptideย productionย capacity with newly-upgraded facilities atย CordenPharmaย Colorado, theย largestย Solid-Phaseย Peptideย Synthesis (SPPS)ย Manufacturingย facilityย worldwide. After kicking off capital investments in early 2023,ย CordenPharmaย successfully completed a series of upgrades and modernizations to the...

Torx Software announces global drug discovery collaboration with CDD Vault

Torx Software Limited, announces a collaboration with CDD Vault to facilitate the seamless synthesis and registration of new compounds during the small-molecule drug discovery process. Torx is a cloud-based platform developed by Cresset and Elixirโ„ข Software, which enables chemistry teams...

UK Returns To Horizon Europe Boosting Life Sciences Growth

The United Kingdom has once again become a part of Horizon Europe through a fresh agreement with the European Union. This development opens up opportunities for British scientists to engage in the world's largest research and development collaboration program....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป